2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow concizumab: new trials by email Literature Review of concizumab trials Research Report on concizumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial Evaluating Efficacy and Safety of Prophylactic Administration of Concizumab in Patients With Severe Haemophilia A Without Inhibitors Concizumab, Turoctocog alfa - Haemostasis, Haemophilia A | Phase 2 | Completed | Novo Nordisk A/S | 36 | 2017-08-16 | 2021-11-16 |
| A Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B Patients With Inhibitors Concizumab, Eptacog alfa - Congenital Bleeding Disorder, Haemophilia A With Inhibitors | Phase 2 | Completed | Novo Nordisk A/S | 26 | 2017-08-10 | 2021-10-22 |
Hemophilia A (1)
Novo Nordisk A/S (2)
Italy (2) · Japan (2) · Spain (2) · Sweden (2) · Ukraine (2) · United Kingdom (2) · United States (2) · Austria (1) · Canada (1) · Croatia (1) · Denmark (1) · France (1) · Germany (1) · Greece (1) · Israel (1)
2016 (2)